Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Active array substrate and method for manufacturing the same
Method and device for switching video pictures
Disposable fluid dispenser
Image forming apparatus including an image calibration system
Systems and methods for searching using queries written in a different character-set and/or language from the target pages
Vehicle grille
Trunk lid for a vehicle
  Randomly Featured Patents
Mirror or the like
Nitride bonded oxide refractories
Magnetic tunneling junction antifuse device
Automatic focus control device for use in a camera system
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1
Electrical connector assembly
Adjustable wrench
Extensible architecture for the centralized discovery and management of heterogeneous SAN components
Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same
Collar for palletized load